Our whole-genome microarray-analysis data showed that primary CRLF2 B-ALL cells from patient-1 upregulated the expression of SOCS genes (CISH, SOCS1, SOCS2, and SOCS 3) in response to high-TSLP (15,000 pg/mL) treatment ex vivo. The gene discussed is TSLP; the disease is acute lymphoblastic leukemia.